The Discounted Cash Flow (DCF) valuation of Amphastar Pharmaceuticals Inc (AMPH) is 38.60 USD. With the latest stock price at 20.62 USD, the upside of Amphastar Pharmaceuticals Inc based on DCF is 87.2%.
Based on the latest price of 20.62 USD and our DCF valuation, Amphastar Pharmaceuticals Inc (AMPH) is a buy. buying AMPH stocks now will result in a potential gain of 87.2%.
Range | Selected | |
WACC / Discount Rate | 6.5% - 9.8% | 8.1% |
Long-term Growth Rate | 0.0% - 1.0% | 0.5% |
Fair Price | 28.88 - 55.93 | 38.60 |
Upside | 40.1% - 171.3% | 87.2% |